Inactivation of CMY-2 beta-lactamase by tazobactam: initial mass spectroscopic characterization.
The CMY-2 beta-lactamase, a plasmid determined class C cephalosporinase, was shown to be susceptible to inhibition by tazobactam (K(i)=40 microM). The reaction product(s) of CMY-2 beta-lactamase with the beta-lactamase inhibitor tazobactam were analyzed by electrospray ionization/mass spectrometry (ESI/MS) to characterize the prominent intermediates of the inactivation pathway. The ESI/MS determined mass of CMY-2 beta-lactamase was 39851+/-3 Da. After inactivating CMY-2 beta-lactamase with excess tazobactam, a single species, M(r)=39931+/-3.0, was detected. Comparison of the peptide maps from tryptic digestion of the native enzyme and the inactivated beta-lactamase followed by LC/MS identified two 22 amino acid peptides containing the active site Ser64 modified by a fragment of tazobactam. These two peptides were increased in mass by 70 and 88 Da, respectively. UV difference spectra following inactivation revealed the presence of a new species with a 302 nm lambda(max). Based upon the increase in molecular mass of the tazobactam inactivated CMY-2 beta-lactamase, we propose that during the inactivation of this beta-lactamase by tazobactam an imine is formed. Tautomerization forms the spectrally observed enamine. Hydrolysis generates the covalently attached malonyl semialdehyde, its hydrate, or an enol. This work provides information on the mass of a stable enzyme intermediate of a class C beta-lactamase inactivated by tazobactam and, for the first time, unequivocal evidence that a cross-linked species is not required for apparent inactivation.
Bonomo
R A
RA
Infectious Disease Section, Louis Stokes Veterans Affairs Medical Center, Cleveland, OH 44106, USA. robert.bonomo@med.va.gov
Liu
J
J
Chen
Y
Y
Ng
L
L
Hujer
A M
AM
Anderson
V E
VE
D000595:Amino Acid Sequence; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D013058:Mass Spectrometry / Q000379:methods; D008956:Models, Chemical; D008969:Molecular Sequence Data; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000078142:Tazobactam; D014357:Trypsin; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000737:chemistry*
D004791:Enzyme Inhibitors; D065093:beta-Lactamase Inhibitors; D010397:Penicillanic Acid; D014357:Trypsin; C103022:beta-lactamase CMY-2; D001618:beta-Lactamases; D000078142:Tazobactam